He was involved in the launch of Alosetron for the treatment of IBS, has progressed more than 30 clinical candidates, many of these into Phase II studies and 5 into Phase III studies. His ...
Recently, there has been strong interest in the therapeutic potential of probiotics for irritable bowel syndrome (IBS). At the same time, there is a rapidly growing body of evidence to support an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback